Integrated e-Health (Electronic Health) for HIV and Substance Use Disorders in Justice Involved Women

Description

The purpose of this 2-site (CT, AL) study is to test innovative interventions to reduce stigma and improve the pre-exposure prophylaxis (PrEP) and opioid use disorder (OUD) care continua in women involved in the criminal justice system (WICJ). This study evaluates a newly validated PrEP decision aid and eHealth for integrated PrEP and MOUD compared to a decision aid-only for WICJ with OUD.

Conditions

HIV, Opioid Use Disorder, eHealth

Talk to us

Study Overview

On this page

Study Details

Study overview

The purpose of this 2-site (CT, AL) study is to test innovative interventions to reduce stigma and improve the pre-exposure prophylaxis (PrEP) and opioid use disorder (OUD) care continua in women involved in the criminal justice system (WICJ). This study evaluates a newly validated PrEP decision aid and eHealth for integrated PrEP and MOUD compared to a decision aid-only for WICJ with OUD.

Integrated eHealth for HIV and Substance Use Disorders in Justice Involved Women

Integrated e-Health (Electronic Health) for HIV and Substance Use Disorders in Justice Involved Women

Condition
HIV
Intervention / Treatment

-

Contacts and Locations

Birmingham

University of Alabama in Birmingham, Birmingham, Alabama, United States, 35294

New Haven

Yale University, New Haven, Connecticut, United States, 06519

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * cis-women
  • * have access to a working mobile or landline phone
  • * CJ-involved (currently on probation, parole, intensive pretrial or community supervision, or are within 12 months after release from prison/jail
  • * are confirmed HIV-negative by point-of-care 3rd generation HIV antibody test
  • * meet clinical criteria for PrEP
  • * have opioid use disorder (regardless of baseline treatment status)
  • * unable or unwilling to provide informed consent
  • * pregnant or breast-feeding
  • * currently taking PrEP at the time of study enrollment
  • * not comfortable conversing in English or Spanish.

Ages Eligible for Study

18 Years to 59 Years

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Yale University,

Carolina Price, MPA, STUDY_DIRECTOR, Yale University

Jaimie P Meyer, MD, MS, FACP, PRINCIPAL_INVESTIGATOR, Yale University

Study Record Dates

2027-04-01